At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.

Fintel reports that on July 31, 2025, HSBC downgraded their outlook for Novo Nordisk A (NYSE:NVO) from Buy to Hold. Analyst ...

Donald Trump is pressuring the world’s biggest drug makers to raise prices outside of the US in a threat to the NHS.

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, ...

Novo Nordisk's launch of NovoCare is showing signs of boosting Wegovy's sales, and the E.U.-U.S. trade deal adds stability ...

Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...

Eli Lilly's stock took a noticeable dip following a guidance update from rival Novo Nordisk. Investors reacted sharply as ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: ...

Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

Hundreds of tenants from across Massachusetts descended on Beacon Hill Tuesday to show their support for rent stabilization ...